. The Amyloid-β Oligomer Count in Cerebrospinal Fluid is a Biomarker for Alzheimer's Disease. J Alzheimers Dis. 2013 Jan 1;34(4):985-94. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Oligomer Assay Finds Similar Aβ Profiles in AD and in Mice

Mutations